Racial representation in multicenter clinical trials leading to drug approvals for gynecological cancer indications by the US Food and Drug Administration (FDA).
| Autor: | Ibanez, Kristen R., Khan, Maheen, Donohue, Duncan, Oluloro, Ann, Swisher, Elizabeth M., Lee, Jung-Min |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p66-66, 34p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|